Parietal foramina with clavicular hypoplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251290OMIM:168550Q74.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Parietal foramina with clavicular hypoplasia (PFHC) is an extremely rare genetic skeletal disorder characterized by the combination of two distinctive bone abnormalities: enlarged parietal foramina (symmetrical openings or defects in the parietal bones of the skull) and hypoplasia (underdevelopment) of the clavicles (collarbones). The parietal foramina result from incomplete ossification of the parietal bones during fetal development and are typically present from birth. The clavicular hypoplasia can range from mild shortening to more significant underdevelopment of the collarbones. This condition primarily affects the skeletal system, specifically the craniofacial and shoulder girdle regions. This condition is caused by heterozygous mutations in the MSX2 gene on chromosome 5q35.2, which encodes a homeobox transcription factor critical for bone development and cranial suture closure. The MSX2 gene plays an important role in osteoblast differentiation and skeletal patterning. Parietal foramina with clavicular hypoplasia shares genetic overlap with isolated parietal foramina (caused by MSX2 or ALX4 mutations), but the additional clavicular involvement distinguishes this specific entity. Key clinical features include the persistent symmetrical skull defects, which may be palpable as soft areas on the top of the head, and shortened or underdeveloped collarbones, which may affect shoulder width and mobility. There is no specific curative treatment for this condition. Management is generally supportive and based on clinical findings. In most cases, the parietal foramina tend to decrease in size with age as ossification progresses, though they may persist into adulthood. Protective headgear may be recommended in early childhood to prevent injury to the brain through the skull defects. Surgical intervention is rarely needed but may be considered for large persistent defects. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Parietal foramina with clavicular hypoplasia.

View clinical trials →

No actively recruiting trials found for Parietal foramina with clavicular hypoplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Parietal foramina with clavicular hypoplasia community →

No specialists are currently listed for Parietal foramina with clavicular hypoplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Parietal foramina with clavicular hypoplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Parietal foramina with clavicular hypoplasiaForum →

No community posts yet. Be the first to share your experience with Parietal foramina with clavicular hypoplasia.

Start the conversation →

Latest news about Parietal foramina with clavicular hypoplasia

No recent news articles for Parietal foramina with clavicular hypoplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Parietal foramina with clavicular hypoplasia

What is Parietal foramina with clavicular hypoplasia?

Parietal foramina with clavicular hypoplasia (PFHC) is an extremely rare genetic skeletal disorder characterized by the combination of two distinctive bone abnormalities: enlarged parietal foramina (symmetrical openings or defects in the parietal bones of the skull) and hypoplasia (underdevelopment) of the clavicles (collarbones). The parietal foramina result from incomplete ossification of the parietal bones during fetal development and are typically present from birth. The clavicular hypoplasia can range from mild shortening to more significant underdevelopment of the collarbones. This condi

How is Parietal foramina with clavicular hypoplasia inherited?

Parietal foramina with clavicular hypoplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Parietal foramina with clavicular hypoplasia typically begin?

Typical onset of Parietal foramina with clavicular hypoplasia is neonatal. Age of onset can vary across affected individuals.